
Mikatax Mdv 500mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Amikacin (500mg)
Overview Mikatax Mdv 500mg Injection
Ceftazidime 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. It also proactively prevents infections in hospitalized individuals. This antibiotic functions by inhibiting bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-administration is strictly prohibited. Consistent use at prescribed intervals is crucial. Complete the entire course, even with symptom improvement; premature discontinuation risks relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Adherence to physician instructions, including routine kidney function, hearing, and urinalysis, is imperative. Pregnancy is a contraindication; notify your physician if pregnant, planning pregnancy, or breastfeeding.
Uses of Mikatax Mdv 500mg Injection
Infections caused by bacteria
Major Benefits of Mikatax Mdv 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mikatax Mdv 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikatax Mdv 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mikatax Mdv 500mg Injection works:
Mikatax Mdv 500mg Injection is a bacterial growth inhibitor, a type of antibiotic that functions by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mikatax Mdv 500mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mikatax Mdv 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Mikatax Mdv 500mg injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administering Mikatax Mdv 500mg Injection could induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Mikatax Mdv 500mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikatax Mdv 500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Mikatax Mdv 500mg Injection :
Should you inadvertently omit a scheduled dose of Mikatax Mdv 500mg Injection, seek immediate medical advice.
Facts to Know About Mikatax Mdv 500mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino-glycoside antibiotics |
| Addictive | None. |
| Medication Classification | Microbial agents' antagonists |
| Mechanism of Action | Aminoglycoside antibiotics |
